Effect of Transcutaneous Electrical Nerve Stimulation Based on Wrist-ankle Acupuncture Theory on Postoperative Pain After Video-assisted Thoracoscopic Surgery

December 30, 2025 updated by: Jia-feng Wang, Changhai Hospital

At present, surgical resection remains one of the main methods for the radical treatment of lung cancer. Compared with traditional thoracotomy, Video-assisted Thoracoscopic Surgery (VATS) offers obvious advantages, such as less surgical trauma and rapid postoperative recovery. However, a certain proportion of patients will still experience moderate to severe pain after undergoing VATS. Postoperative acute pain can lead to increased postoperative pulmonary complications, prolonged hospital stays, and increased treatment costs. Additionally, it is also associated with the development of postoperative chronic pain. Therefore, effective pain management after VATS is crucial.

Researchers will compare Transcutaneous Electrical Nerve Stimulation (TENS) based on Wrist-Ankle Acupuncture theory (TENS-WAA) with a sham stimulation regimen to determine whether TENS-WAA can relieve postoperative pain in patients undergoing thoracoscopic lung resection. This study aims to enrich the existing postoperative analgesia schemes and provide a reliable basis for its clinical promotion.

Study Overview

Study Type

Interventional

Enrollment (Actual)

156

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, China, 200090
        • Changhai Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients aged over 18 years
  • American Society of Anesthesiologists (ASA) physical status of I-III
  • Patients scheduled for elective unilateral lobectomy via video-assisted thoracoscopic surgery (VATS) for lung cancer under general anesthesia
  • Informed consent signed

Exclusion Criteria:

  • History of liver, kidney, heart, lung, or brain disease
  • Psychiatric disorder or cognitive impairment
  • Chronic pain, daily use of analgesics, or alcohol dependence
  • Routine or recent acupuncture treatment
  • Contraindications to TENS (with pacemaker or metallic implants, allergy to surface electrodes, with skin sensory disorders, skin ulceration, unhealed scars, or adhesions)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: TENS-WAA group
Patients assigned to the TENS-WAA group will receive transcutaneous electrical nerve stimulation (TENS) based on Wrist-Ankle Acupuncture theory (WAA) for a duration of 30 minutes after anesthesia induction, as well as at 8 hours and 24 hours postoperatively.
Patients assigned to the TENS-WAA group will receive transcutaneous electrical nerve stimulation based on Wrist-Ankle Acupuncture theory for a duration of 30 minutes after anesthesia induction, as well as at 8 hours and 24 hours postoperatively. According to the principles of WAA, two pairs of TENS-WAA (Wuxi Jiajian Medical Device Co., Ltd.) electrode pads will be placed on the upper area 2 and 3 with the skin of the treatment area exposed, and the upper and lower juxtaposition method will be adopted. Upper area 2 is at the middle of the palmar side of the forearm, between the palmaris longus and flexor carpi radialis. Upper area 3 is between the edge of the radius and the radial artery. Stimulation parameters of TENS-WAA are alternating dense-disperse wave with a frequency of 2Hz and a pulse width of 200μs, and a frequency of 100Hz with a pulse width of 150μs, alternating every 3 seconds ,intensity required to reach the maximum tolerable level without causing pain.
Sham Comparator: sham TENS-WAA group
Patients assigned to the sham TENS-WAA group will receive sham stimulation (without stimulation)for a duration of 30 minutes after anesthesia induction, as well as at 8 hours and 24 hours postoperatively.
Patients assigned to the sham TENS-WAA group will receive sham stimulation for a duration of 30 minutes after anesthesia induction, as well as at 8 hours and 24 hours postoperatively. Researchers will attach the electrode patches at the same location, set the parameters to the same frequency, pulse width, and minimum current intensity as the TENS-WAA group, but do not activate the device, leaving it in place for 30 minutes at each time point.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The dynamic VAS score
Time Frame: at 24 hours after surgery
Independent investigators will assess the postoperative dynamic pain (pain during activities or coughing) by utilizing a visual analogue scale (VAS) ranging from 0 to 10. The two ends of the straight line represent "no pain at all" and "the worst pain imaginable," respectively. Patients are required to mark their corresponding position on the line based on their perception of pain, and the numerical value corresponding to this position serves as the patient's pain score.
at 24 hours after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The static VAS score
Time Frame: at 6 hours, 12 hours, 24 hours and 48 hours after surgery
Postoperative static pain (pain at rest) will be quantified using the VAS.
at 6 hours, 12 hours, 24 hours and 48 hours after surgery
The dynamic VAS score
Time Frame: at 6 hours, 12 hours and 48 hours after surgery
Postoperative dynamic pain (pain during activities or coughing) will be quantified using the VAS.
at 6 hours, 12 hours and 48 hours after surgery
Opioid consumption during surgery
Time Frame: at the end of the surgery
The consumption of opioids during the surgery will be converted into morphine equivalent, and then the total will be calculated.
at the end of the surgery
Postoperative opioid consumption
Time Frame: at 48 hours after surgery
The consumption of opioids within 48 hours after surgery will be converted into morphine equivalent.
at 48 hours after surgery
Consumption of NSAIDs
Time Frame: at 48 hours after surgery
The consumption of Non-steroidal Anti-inflammatory Drugs within 48 hours after surgery will be recorded.
at 48 hours after surgery
The 15-item QoR score
Time Frame: at 24 hours and 48 hours after surgery
The 15-item QoR score is used to assess the quality of recovery after surgery, which ranges from 0 to 150, and higher QoR-15 scores indicate better postoperative recovery.
at 24 hours and 48 hours after surgery
The HADS score
Time Frame: at 24 hours and 48 hours after surgery
The Hospital Anxiety and Depression Scale (HADS) is used to evaluate patients' anxiety and depression. Scores on the HADS range from 0 to 21, and higher scores indicate more severe anxiety or depression.
at 24 hours and 48 hours after surgery
The AIS score
Time Frame: The morning of the first day after surgery and the morning of the second day after surgery.
The Athens Insomnia Scale (AIS) is used to assess the quality of sleep after surgery. Scores on the AIS range from 0 to 24, and higher scores indicate worse sleep quality.
The morning of the first day after surgery and the morning of the second day after surgery.
Incidence of PONV
Time Frame: at 48 hours after surgery
The researchers will observe whether patients experience nausea and vomiting after surgery.
at 48 hours after surgery
The duration of hospital stay
Time Frame: on the 1 day of the patient's discharge from the hospital
The period from the end of surgery to the patient's discharge from the hospital will be recorded.
on the 1 day of the patient's discharge from the hospital

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jiafeng Wang, M.D., Changhai hospital, Shanghai, China

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 6, 2025

Primary Completion (Actual)

June 20, 2025

Study Completion (Actual)

June 20, 2025

Study Registration Dates

First Submitted

December 15, 2024

First Submitted That Met QC Criteria

December 19, 2024

First Posted (Actual)

December 20, 2024

Study Record Updates

Last Update Posted (Actual)

December 31, 2025

Last Update Submitted That Met QC Criteria

December 30, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Pain

Clinical Trials on TENS-WAA

Subscribe